Send us a link
Data Carpentry workshops teach skills to researchers to enable them to retrieve, view, manipulate, analyze and store their and other’s data in an open and reproducible way in order to extract knowledge from data.
Research policies that better incentivise data sharing are needed to improve the quality of research results and foster scientific progress.
Bernard Rentier explains how the University of Liege persuaded nearly all its researchers to put their papers in its institutional repository.
Jimmy Wales co-founder of Wikipedia asked to reconsider arrangement with paywalled science publisher Elsevier.
PLOS has identified a set of established repositories, which are recognized and trusted within their respective communities.
Interview with Mark Hahnel , founder of the data sharing platform [26]Figshare and keynote speaker on "Open Science" at [27]ScienceComm'15.
The aim is to specify a standard by which we can say that a scientific study has been conducted in accordance with open-science principles and provide visual icons to allow advertising of such good behaviours.
The data transparency revolution is gathering pace. Last month, the WHO and the Nordic Trial Alliance released important declarations about clinical trial transparency.
Data.gov now enables the public to open data directly with apps like Plotly and CartoDB for robust visualization and analysis. New tools are making it easier to visualize and analyze data at the click of a button.
openSNP allows customers of direct-to-customer genetic tests to publish their test results, find others with similar genetic variations, learn more about their results, get the latest primary literature on their variations and help scientists find new associations.
A Survey of Researchers Submitting to Data Repositories
The Institute of Medicine takes a step in the right direction but we should move even faster.
The state of government open data across the globe in 2014. Switzerland has space for improvement.
PLOS open-data mandate has prompted scientists to share more data online, but not everyone is complying with the regulations.
The Public Library of Science’s open-data mandate has prompted scientists to share more data online, but not everyone is complying with the regulations.
The free IPython notebook makes data analysis easier to record, understand and reproduce.
As appeals for public access of research data continue to proliferate, many scholarly publishers-alongside funders, institutions, and libraries-are expanding their role to address this need.
We’ve developed an enriched format for citations, called, appropriately enough, rich citations.
Realising the innovative potential of digital research methods: a call from the research community.
Accessing government data from the source is frustrating. If you've done it, or at least tried to, you know the pain that is oddly formatted files, search that doesn't work, and annotation that tells you nothing about the data in front of you.
Is 2014 the year that Europe gets drug companies to publish all their data on the safety and effectiveness of medicines?
The academic torrents network is built for researchers, by researchers. Its distributed peer-to-peer library system automatically replicates your datasets on many servers, so you don't have to worry about managing your own servers or file availability. Everyone who has data becomes a mirror for those data so the system is fault-tolerant.
Knowledge generated with public funds should be accessible to everyone, says Dr Al Shorbaji, Director of Knowledge, Ethics and Research at WHO.
re3data.org presents repositories for the permanent storage and access of data sets to researchers, funding bodies, publishers and scholarly institutions. re3data.org aims to promote a culture of sharing, increased access and better visibility of research data.
Broken e-mails and obsolete storage devices were the main obstacles to data sharing. Policies mandating data archiving at publication are clearly needed.
As public pressure builds for drug companies to make more results available from clinical trials, the industry should not forget that it relies on collective goodwill to test new therapies.
